SCHEMBL7485189

SCHEMBL7485189

CCCCOC(=O)N1CCC(O)(c2ccc(Cl)cc2)C1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 2/20 0.45
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
OPRD1 P41143 1/20 0.44
OPRK1 P41145 1/20 0.44
APP P05067 1/20 0.43
DRD2 P14416 2/20 0.43
HTR1A P08908 1/20 0.43
DRD1 P21728 1/20 0.43
DRD5 P21918 1/20 0.43
SLC6A2 P23975 1/20 0.43
HTR2A P28223 1/20 0.43
SLC6A4 P31645 1/20 0.43
HTR7 P34969 1/20 0.43
HRH1 P35367 1/20 0.43
DRD3 P35462 1/20 0.43
HTR2B P41595 1/20 0.43
ADRA1A P35348 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16244844 0.93 CCR1 (0.49) CCR1KDM4EMEN1KMT2AOPRD1
SCHEMBL3278197 0.89 APP (0.53) CCR1KDM4EMEN1KMT2AAPP
SCHEMBL7478597 0.88 MEN1 (0.48) CCR1KDM4EMEN1KMT2AOPRD1
SCHEMBL19212251 0.84 OPRD1 (0.43) OPRD1OPRK1HTR2AHTR7HRH1
SCHEMBL16245128 0.81 DRD2 (0.48) KMT2AOPRD1OPRK1APPDRD2
SCHEMBL6248104 0.81 KMT2A (0.54) MEN1KMT2AOPRD1OPRK1APP
SCHEMBL3467822 0.79 EPHX2 (0.53) OPRD1OPRK1HRH1
SCHEMBL29087269 0.79 CCR1 (0.59) CCR1MEN1KMT2AOPRD1OPRK1
SCHEMBL23112637 0.78 LMNA (0.43) OPRD1OPRK1DRD2HTR1ADRD1
SCHEMBL23112776 0.78 HRH2 (0.44) MEN1KMT2AAPPHRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1204665-A2 CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREFOR Millennium Pharmaceuticals, Inc. (US) 2002-05-15 EP disclosed
WO-2001009138-A2 CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREFOR MILLENNIUM PHARMACEUTICALS, INC. (US) 2001-02-08 WO disclosed